Innate and Adaptive Immunity in Cystic Fibrosis

73Citations
Citations of this article
114Readers
Mendeley users who have this article in their library.
Get full text

Abstract

Cystic fibrosis (CF) lung disease is characterized by persistent and unresolved inflammation, with elevated proinflammatory and decreased anti-inflammatory cytokines, and greater numbers of immune cells. Hyperinflammation is recognized as a leading cause of lung tissue destruction in CF. Hyper-inflammation is not solely observed in the lungs of CF patients, since it may contribute to destruction of exocrine pancreas and, likely, to defects in gastrointestinal tract tissue integrity. Paradoxically, despite the robust inflammatory response, and elevated number of immune cells (such as neutrophils and macrophages), CF lungs fail to clear bacteria and are more susceptible to infections. Here, we have summarized the current understanding of immune dysregulation in CF, which may drive hyperinflammation and impaired host defense.

Cite

CITATION STYLE

APA

Bruscia, E. M., & Bonfield, T. L. (2016, March 1). Innate and Adaptive Immunity in Cystic Fibrosis. Clinics in Chest Medicine. W.B. Saunders. https://doi.org/10.1016/j.ccm.2015.11.010

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free